Jean-marc Combette

1 Patent

• US117796282023

  Use of Cell-permeable Peptide Inhibitors of the JNK Signal Transduction Pathway for the Treatment of Various Diseases

  XIGEN INFLAMMATION Ltd.

  0 cites